We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Pfizer Inc | NYSE:PFE | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.15 | 0.59% | 25.79 | 121,591 | 12:42:06 |
By Michael Dabaie
Moderna Inc. said the U.S. Food and Drug Administration extended the emergency use authorization of a booster dose of its Covid-19 vaccine at the 50-microgram level to all adults aged 18 and older, sending shares higher in premarket trade.
This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved Covid-19 vaccine, the company said.
Moderna shares rose 6% to $267.43 in premarket trade.
The booster dose is to be administered at least six months after completion of any primary series Covid-19 vaccination.
In October, the FDA authorized for emergency use a booster dose of Moderna's vaccine for people aged 65 and older, as well as adults 18 to 64 at high risk of severe Covid-19 and people 18 to 64 with frequent institutional or occupational exposure to SARS-CoV-2.
"This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country," said Chief Executive Stephane Bancel.
In addition, Pfizer Inc. and BioNTech SE said Friday the FDA expanded the emergency use authorization of a booster dose of the their Covid-19 Vaccine to include individuals 18 years of age and older.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
November 19, 2021 08:49 ET (13:49 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Pfizer Chart |
1 Month Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions